Regenxbio (RGNX) Capital Expenditures Growth (5y) (2020 - 2025)
Regenxbio (RGNX) Capital Expenditures Growth (5y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Regenxbio | 501.81 Mn | 271.74 Mn | 21.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -40.25% |
| Sep 30, 2025 | 17.70% |
| Jun 30, 2025 | -24.23% |
| Mar 31, 2025 | -26.05% |
| Dec 31, 2024 | -21.15% |
| Sep 30, 2024 | 17.47% |
| Jun 30, 2024 | -19.48% |
| Mar 31, 2024 | -25.67% |
| Dec 31, 2023 | -77.61% |
| Sep 30, 2023 | 36.25% |
| Jun 30, 2023 | -36.63% |
| Mar 31, 2023 | 15.50% |
| Dec 31, 2022 | -23.98% |
| Sep 30, 2022 | 40.29% |
| Jun 30, 2022 | -54.63% |
| Mar 31, 2022 | 30.22% |
| Dec 31, 2021 | -76.59% |
| Sep 30, 2021 | 89.13% |
| Jun 30, 2021 | -36.05% |
| Mar 31, 2021 | 55.11% |